Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Technology-Mediated Public Speaking Interventions for Educational Training and Anxiety Treatment: A Comprehensive Review

Public speaking training and public speaking anxiety (PSA) treatment increasingly rely on technology-mediated systems, including web, mobile, desktop, and immersive virtual reality (VR) tools. This comprehensive review identifies and maps information and communication technology (ICT)-based public speaking interventions for educational training and anxiety-oriented treatment, focusing on platform choice, audience simulation, feedback timing, physiological and behavioral sensing, therapeutic framing, practitioner involvement, and evaluation methods. A PRISMA-inspired process documented identification and screening across Scopus, Web of Science, PubMed, IEEE Xplore, and ERIC for English-language journal articles and conference papers published between 1 February 2015 and 1 February 2025. From 6602 records, 82 participant-validated studies were included. No formal risk-of-bias assessment was conducted. VR accounted for 82.93% of interventions, while research prototypes comprised 72.0% of the evidence base, demonstrating the field’s strong emphasis on immersive and experimental development. At the same time, 64.6% of interventions provided no automated feedback and 36.6% used no physiological or behavioral sensing, highlighting opportunities for more responsive and data-informed systems. The findings can guide the development of future public-speaking training and treatment systems by highlighting recurring design components, promising implementation patterns, and priorities for stronger comparative validation.

Dragoș-Ion Dogioiu, A. A. Morar, A. Moldoveanu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.